Cargando…

Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature

Breast cancer cell lines are frequently used to elucidate the molecular mechanisms of the disease. However, a large proportion of cell lines are affected by problems such as mislabeling and cross-contamination. Therefore, it is of great clinical significance to select optimal breast cancer cell line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Qingzhou, Song, Xuekun, Zhang, Zhenzhen, Zhang, Yizhi, Chen, Yating, Li, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746845/ https://www.ncbi.nlm.nih.gov/pubmed/33344500 http://dx.doi.org/10.3389/fmolb.2020.564005

Ejemplares similares

A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
por: Chen, Yanhua, et al.
Publicado: (2020)

Dynamics Insights Into the Gain of Flexibility by Helix-12 in ESR1 as a Mechanism of Resistance to Drugs in Breast Cancer Cell Lines
por: Khan, Abbas, et al.
Publicado: (2020)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

A Metabolic Gene Signature to Predict Breast Cancer Prognosis
por: Lu, Jun, et al.
Publicado: (2022)

Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer
por: Dong, Bingqi, et al.
Publicado: (2021)

Identification of a Diagnostic Signature and Immune Cell Infiltration Characteristics in Keloids
por: Xia, Yijun, et al.
Publicado: (2022)

Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis
por: Cao, Mingde, et al.
Publicado: (2020)

Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
por: Li, Huihui, et al.
Publicado: (2022)

Biased Influences of Low Tumor Purity on Mutation Detection in Cancer
por: Cheng, Jun, et al.
Publicado: (2020)

A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021)

Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma
por: Dai, Zili, et al.
Publicado: (2021)

Identification of Five Ferroptosis-Related LncRNAs as Novel Prognosis and Diagnosis Signatures for Renal Cancer
por: Shu, Xiangjun, et al.
Publicado: (2022)

Breast Cancer; Discovery of Novel Diagnostic Biomarkers, Drug Resistance, and Therapeutic Implications
por: Afzal, Samia, et al.
Publicado: (2022)

Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021)

Identification of a Novel Protein-Based Signature to Improve Prognosis Prediction in Renal Clear Cell Carcinoma
por: Chu, Guangdi, et al.
Publicado: (2021)

Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype
por: Bai, Shuang, et al.
Publicado: (2021)

Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Identification of novel gene signatures and immune cell infiltration in intervertebral disc degeneration using bioinformatics analysis
por: Tang, Tao, et al.
Publicado: (2023)

Proteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
por: Moreira, Ana M., et al.
Publicado: (2022)

Identification and validation of a novel tumor driver gene signature for diagnosis and prognosis of head and neck squamous cell carcinoma
por: Liu, Shixian, et al.
Publicado: (2022)

Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma
por: Zhang, Guangyuan, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles
por: Ling, Bo, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer
por: Liu, Bangquan, et al.
Publicado: (2022)

Immune Cell Infiltration and Relevant Gene Signatures in the Tumor Microenvironment that Significantly Associates With the Prognosis of Patients With Breast Cancer
por: Xu, Qiang, et al.
Publicado: (2022)

Three E2F target-related genes signature for predicting prognosis, immune features, and drug sensitivity in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2023)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification of Pyroptosis-Related Gene Signatures and Construction of the Risk Model to Predict BCR in Prostate Cancer
por: Wang, Miaomiao, et al.
Publicado: (2022)

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
por: Yao, Yihan, et al.
Publicado: (2020)

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer
por: Long, Gongwei, et al.
Publicado: (2021)

The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance
por: Cao, Shulong, et al.
Publicado: (2021)

Identification of a polyamine-related signature and six novel prognostic biomarkers in oral squamous cell carcinoma
por: Tang, Jiezhang, et al.
Publicado: (2023)

Identification of a Novel Ferroptosis Inducer for Gastric Cancer Treatment Using Drug Repurposing Strategy
por: Zhang, Jinping, et al.
Publicado: (2022)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Identification of Mast Cell-Based Molecular Subtypes and a Predictive Signature in Clear Cell Renal Cell Carcinoma
por: Liu, Hanxiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84lsddv0k9i0qmmjcgttdtrvhm